Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

Urology

Volumn 66, Issue 4, 2005, Pages 830-834

  Malaeb, Bahaa S ^b   Gardner, Thomas A ^b   Margulis, Vitaly ^b   Yang, Ling ^b   Gillenwater, Jay Y ^b   Chung, Leland W K ^b   Macik, Gail ^b   Koeneman, Kenneth S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HIGH MOLECULAR WEIGHT KININOGEN; LUPUS ANTICOAGULANT; OSTEOCALCIN; PREKALLIKREIN; THYMIDINE KINASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOSAFETY; BLEEDING; BLOOD CLOTTING DISORDER; BONE METASTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; LYMPH NODE METASTASIS; MALE; PARAAORTIC LYMPH NODE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSTATE CANCER; THROMBOEMBOLISM; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; GENE THERAPY; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PARTIAL THROMBOPLASTIN TIME; PROSTATIC NEOPLASMS;

EID: 26644466325     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.04.041     Document Type: Article

References (26)

1. J. Cheon, S.C. Ko, T.A. Gardner Chemogene therapy osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model Cancer Gene Ther 4 1997 359 365
2. K.S. Koeneman, F. Yeung, L.W. Chung Osteomimetic properties of prostate cancer cells a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment Prostate 39 1997 246 261
3. K.S. Koeneman, C. Kao, S. Ko Osteocalcin-directed gene therapy for prostate cancer bone metastasis World J Urol 18 2000 102 110
4. H. Kubo, T. Gardner, Y. Wada Phase I dose escalation trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer Hum Gene Ther 14 2003 227 241
5. D.H. Sterman, J. Treat, L.A. Litzky Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy results of a phase I clinical trial in malignant mesothelioma Hum Gene Ther 9 1998 1083 1092
6. J.R. Herman, H.L. Adler, E. Aguilar-Cordova In situ gene therapy for adenocarcinoma of the prostate a phase I clinical trial Hum Gene Ther 10 1999 1239 1249
7. D.W. Beck, R.G. Strauss, C.T. Kisker An intrinsic coagulation pathway inhibitor in a 3-year-old child Am J Clin Pathol 71 1979 470 472
8. U. Jaeger, S. Kapiotis, I. Pabinger Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection Ann Hematol 67 1993 95 99
9. L.R. Krilov, L.G. Rubin, M. Frogel Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states Rev Infect Dis 12 1990 303 307
10. K. Bojang, M.D. Walters Toxic shock-like syndrome caused by adenovirus infection Arch Dis Child 67 1992 1112 1114
11. B.A. Dudding, S.C. Wagner, J.A. Zeller Fatal pneumonia associated with adenovirus type 7 in three military trainees N Engl J Med 286 1972 1289 1292
12. S. Ladish, F.H. Lovejoy, J.C. Hierholzer Extrapulmonary manifestations of adenovirus type 7 pneumonia simulating Reye syndrome and the possible role of an adenovirus toxin J Pediatr 95 1979 348 355
13. J.D. Murray, P.K. Kelley, K.L. McClain Adenovirus and childhood immune thrombocytopenic purpura (letter) Am J Hematol 47 1994 65
14. G.A. Prince, D.D. Porter, A.B. Jenson Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus) J Virol 67 1993 101 111
15. A. Lieber, C.Y. He, L. Meuse The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors J Virol 71 1997 8798 8807
16. K. Brand, W. Arnold, T. Bartels Liver associated toxicity of the HSV-tk/GCV approach and adenoviral vectors Cancer Gene Ther 4 1997 9 16
17. L.L. Nielsen, M. Gurnani, J. Syed Recombinant E1-deleted adenovirus-mediated gene therapy for cancer efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models Hum Gene Ther 9 1998 681 694
18. M.M. van der Eb, S.J. Cramer, Y. Vergouwe Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration Gene Ther 5 1998 451 458
19. H. Kurata, C.B. Liu, J. Valkova Recombinant adenovirus vectors for cytokine gene therapy in mice J Allergy Clin Immunol 103 5 Pt 2 1999 S471 S484
20. Lozier J: NIH, Discussion. Presented at the American Society of Gene Therapy Third Annual Meeting, Denver, Colorado, June, 2000.
21. M.A. Morsy, M. Gu, S. Motzel An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene Proc Natl Acad Sci USA 95 1998 7866 7871
22. G. Shiedner, N. Morral, R.J. Parks Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity [published erratum appears in Nat Genet 18: 298, 1998] Nat Genet 18 1998 180 183
23. C.M. Rudin, E.E. Cohen, V.A. Papadimitrakopoulou An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia J Clin 21 2003 4546 4552
24. J. Zhan, Y. Gao, W. Wang Tumor-specific intravenous gene delivery using oncolytic adenoviruses Cancer Gene Ther 12 2005 19 25
25. O. Hamid, M.L. Varterasian, S. Wadler Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer J Clin Oncol 21 2003 1498 1504
26. D.Y. Sze, S.M. Freeman, S.M. Slonim Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival J Vasc Interv Radiol 14 2003 279 290